RecruitingNot Applicable

Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate.

Belgium400 participantsStarted 2021-01-01

Plain-language summary

Assessing whether the use of hyaluronan-enriched transfer medium can increase the cumulative ongoing pregnancy rate

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with own oocytes/embryos; * Patients with female age at 1st OR in the study \<40 year; * Patients planned for a 2nd oocyte retrieval, with no clinical ongoing pregnancy after the previous oocyte retrieval * Patients planned for a 3rd oocyte retrieval with no clinical ongoing pregnancy after previous oocyte retrievals * Patients with female age at 1st OR in the study \<40 year; * Patients with BMI ≤32; * Patients with written informed consent; Exclusion Criteria: \-

What they're measuring

number of transfers needed to reach ongoing pregnancy

Timeframe: ongoing defined as a pregancy with a viable fetus with FHB at 12 weeks of pregnancy

Trial details

NCT IDNCT04697823

SponsorKU Leuven

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Sophie Debrock, PhD

0032016340812 sophie.debrock@uzleuven.be

View on ClinicalTrials.gov More Hyaluronan-EnRiched Medium trials